BMJ reports on poor pain care in Africa due to opiate fear

14 October 2007

The standard of palliative care in Africa is being hit by the reluctance of local health care professionals to use morphine for therapeutic purposes, as well as by poor access to the product, noted the British Medical Journal.

A conference hosted in Nairobi, Kenya, by the Uganda-based African Palliative Care Association, blamed a combination of fear of addiction, excessive bureaucracy, inadequate requisitioning and a reluctance to prescribe morphine outside a hospital context for the lack of support in African countries. In addition to these obstacles, the BMJ's report of the event cited logistical concerns including: the shortage of physicians in rural areas especially; the emphasis on infectious disease programs; geography; the lack of concern among governments and senior medical staff towards deaths.

However, Uganda was singled out as a country where some success have been achieved. Cheap morphine has been made available via trained nurse prescribing. The APCA conference heard that similar improvements are underway in Malawi, Nigeria, Tanzania and Zambia.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight